Brown Brothers Harriman & Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Buy |
|
|||||
|
2025
Q1 | $235K | Hold |
|
|||||
|
2024
Q4 | $205K | Hold |
|
|||||
|
2024
Q3 | $247K | Sell |
|
|||||
|
2024
Q2 | $285K | Sell |
|
|||||
|
2024
Q1 | $336K | Sell |
|
|||||
|
2023
Q4 | $305K | Sell |
|
|||||
|
2023
Q3 | $298K | Sell |
|
|||||
|
2023
Q2 | $308K | Buy |
|
|||||
|
2023
Q1 | $298K | Buy |
|
|||||
|
2022
Q4 | $280K | Hold |
|
|||||
|
2022
Q3 | $234K | Buy |
|
|||||
|
2022
Q2 | $426K | Buy |
|
|||||
|
2022
Q1 | $424K | Buy |
|
|||||
|
2021
Q4 | $280 | Buy |
|
|||||
|
2021
Q3 | $235 | Hold |
|
|||||
|
2021
Q2 | $245 | Sell |
|
|||||
|
2021
Q1 | $228 | Sell |
|
|||||
|
2020
Q4 | $313K | Buy |
|
|||||
|
2020
Q3 | $317K | Sell |
|
|||||
|
2020
Q2 | $359K | Buy |
|
|||||
|
2020
Q1 | $248K | Sell |
|
|||||
|
2019
Q4 | $539K | Buy |
|
|||||
|
2019
Q3 | $372K | Sell |
|
|||||
|
2019
Q2 | $553K | Buy |
|
|||||
|
2019
Q1 | $517K | Buy |
|
|||||
|
2018
Q4 | $240K | Sell |
|
|||||
|
2018
Q3 | $268K | Buy |
|
|||||
|
2018
Q2 | $264K | Sell |
|
|||||
|
2018
Q1 | $286K | Hold |
|
|||||
|
2017
Q4 | $259K | Hold |
|
|||||
|
2017
Q3 | $297K | Hold |
|
|||||
|
2017
Q2 | $315K | Hold |
|
|||||
|
2017
Q1 | $308K | Sell |
|
|||||
|
2016
Q4 | $282K | Buy |
|
|||||
|
2016
Q3 | $315K | Sell |
|
|||||
|
2016
Q2 | $332K | Buy |
|
|||||
|
2016
Q1 | $304K | Hold |
|
|||||
|
2015
Q4 | $303K | Sell |
|
|||||
|
2015
Q3 | $331K | Buy |
|
|||||
|
2015
Q2 | $354K | Sell |
|
|||||
|
2015
Q1 | $564K | Buy |
|
|||||
|
2014
Q4 | $475K | Sell |
|
|||||
|
2014
Q3 | $553K | Buy |
|
|||||
|
2014
Q2 | $599K | Buy |
|
|||||
|
2014
Q1 | $498K | Buy |
|
|||||
|
2013
Q4 | $471K | Sell |
|
|||||
|
2013
Q3 | $448K | Sell |
|
|||||
|
2013
Q2 | $757K | Buy |
|